Metamorphosis of prostate specific membrane antigen (PSMA) inhibitors
Author:
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Structural Biology,Biophysics
Link
https://link.springer.com/content/pdf/10.1007/s12551-021-00919-1.pdf
Reference86 articles.
1. Abdullahi M, Uzairu A, Shallangwa GA, Mamza P, Arthur DE, Ibrahim MT (2020) In-silico modelling studies on some C14-urea-tetrandrine derivatives as potent anti-cancer agents against prostate (PC3) cell line. J King Saud Univ Sci 32:770–779. https://doi.org/10.1016/j.jksus.2019.01.008
2. Anderson MO, Wu LY, Santiago NM, Moser JM, Rowley JA, Bolstad ES, Berkman CE (2007) Substrate specificity of prostate-specific membrane antigen. Bioorg Med Chem 15:6678–6686. https://doi.org/10.1016/j.bmc.2007.08.006
3. Barinka C, Byun Y, Dusich CL, Banerjee SR, Chen Y, Castanares M, Kozikowski AP, Mease RC, Pomper MG, Lubkowski J (2008b) Interactions between human glutamate carboxypeptidase II and urea-based inhibitors: structural characterization. J Med Chem 51:7737–7743. https://doi.org/10.1021/jm800765e
4. Barinka C, Hlouchova K, Rovenska M, Majer P, Dauter M, Hin N, Ko Y-S, Tsukamoto T, Slusher BS, Konvalinka J, Lubkowski J (2008b) Structural basis of interactions between human glutamate carboxypeptidase II and its substrate analogs. J Mol Biol 376:1438–1450. https://doi.org/10.1016/j.jmb.2007.12.066
5. Barinka C, Rinnová M, Sácha P, Rojas C, Majer P, Slusher BS, Konvalinka J (2002) Substrate specificity, inhibition and enzymological analysis of recombinant human glutamate carboxypeptidase II. J Neurochem 80:477–87. https://doi.org/10.1046/j.0022-3042.2001.00715.x
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PSMA-targeted radiotheranostics in modern nuclear medicine: then, now, and what of the future?;Theranostics;2024
2. Glutamate carboxypeptidase II;Metalloenzymes;2024
3. Biophysical Reviews: from the umbra of 2020–2021 into the antumbra of 2022;Biophysical Reviews;2022-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3